FDA Approves Bunavail Buccal Film for the Maintenance Treatment of Opioid Dependence

RALEIGH, N.C., June 9, 2014 /PRNewswire/ — BioDelivery Sciences International, Inc. received approval of the New Drug Application (NDA) for Bunavail (buprenorphine and naloxone) buccal film (CIII) from the U.S. Food and Drug Administration (FDA)….
Drugs.com – New Drug Approvals

Pharmaceutical Stocks

[stock-ticker]

© 2017 Drugs News All rights reserved.       Privacy Policy       Contact Us